Competition and Markets Authority cases and projects

From:: Competition and Markets Authority

This case finder includes cases and projects from the Competition and Markets Authority (CMA), Office for the Internal Market (OIM) and Subsidy Advice Unit (SAU).

Referral of the proposed Life Sciences Innovative Manufacturing Fund by Office for Life Sciences
- Case type: SAU Referral
- Case state: Open
- Market sector: Pharmaceuticals
Theramex/European Rights to Viatris’ Femoston and Duphaston products
- Case type: Mergers
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 20 November 2023
Hydrocortisone tablets: alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct (50277)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
Pharmacy2U / Lloyds Direct merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Healthcare and medical equipment and 2 others
- Outcome type: Mergers - phase 1 clearance
- Opened: 30 November 2023
- Closed: 19 April 2024
Referral of the proposed English Investment Zones Scheme by the Department for Levelling Up, Housing and Communities
- Case type: SAU Referral
- Case state: Closed
- Market sector: Communications and 6 others
- Opened: 4 March 2024
- Closed: 17 April 2024
Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron treatments
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 31 January 2024
Liothyronine tablets: suspected excessive and unfair pricing
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 25 October 2016
Phenytoin sodium capsules: suspected unfair pricing
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter II
- Opened: 1 May 2013
Pharmaceuticals: anti-competitive agreements
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 10 October 2017
Nortriptyline investigation: director disqualification
- Case type: Competition disqualification
- Case state: Open
- Market sector: Pharmaceuticals
Pharmaceutical drugs: suspected anti-competitive agreements
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Opened: 10 October 2017
Paroxetine investigation: anti-competitive agreements and conduct
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 11 August 2011
Nortriptyline investigation: anti-competitive agreement and conduct
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter I
- Opened: 10 October 2017
Investigation into supply of lithium-based medication for the treatment of bipolar disease
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - commitments
- Opened: 5 October 2020
- Closed: 18 December 2020
CSL Behring LLC / uniQure biopharma BV merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 found not to qualify
- Opened: 6 November 2020
- Closed: 27 November 2020
Dechra Pharmaceuticals PLC/Osurnia business of Elanco Animal Health Incorporated Merger Inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 26 March 2020
- Closed: 15 July 2020
Fludrocortisone acetate tablets: anti-competitive agreement (50455)
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter I
- Opened: 10 October 2017
Fludrocortisone acetate tablets: director disqualification
- Case type: Competition disqualification
- Case state: Open
- Market sector: Pharmaceuticals
Roche Holdings, Inc / Spark Therapeutics, Inc merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 10 June 2019
- Closed: 16 December 2019
Pharmaceutical sector: suspected anti-competitive agreements and conduct 50780
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - administrative priorities
- Opened: 10 October 2017
- Closed: 25 November 2019
Hydrocortisone tablets: alleged anti-competitive agreements and abusive conduct (50277-3)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 18 October 2017
Hydrocortisone tablets: alleged anti-competitive agreements and abusive conduct (50277-2)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 12 April 2016
Hydrocortisone tablets: alleged excessive and unfair pricing (50277-1)
- Case type: CA98 and civil cartels
- Case state: Open
- Market sector: Pharmaceuticals
- Opened: 8 March 2016
Remicade: alleged abusive discount scheme
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - no grounds for action
- Opened: 1 December 2015
Baxter, Inc / Hospira UK Limited’s compounding business and related assets merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 18 October 2018
- Closed: 4 January 2019
Pharmaceutical sector: suspected anti-competitive agreements
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Opened: 10 October 2017
- Closed: 14 November 2018
Tiancheng International Investment / Biotest AG merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 2 February 2018
- Closed: 5 June 2018
AAH Pharmaceuticals / MASTA and Sangers merger
- Case type: Mergers
- Case state: Closed
- Market sector: Healthcare and medical equipment and 2 others
- Outcome type: Mergers - phase 1 clearance
- Opened: 8 January 2016
- Closed: 10 August 2016
Vectura / Skyepharma merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 found not to qualify
- Opened: 27 April 2016
- Closed: 24 May 2016
LEO Pharma / Astellas Pharma merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 22 January 2016
- Closed: 5 April 2016
Review of structural merger undertakings given before 1 January 2005
- Case type: Reviews of orders and undertakings
- Case state: Closed
- Market sector: Agriculture, environment and natural resources and 18 others
- Opened: 26 March 2015
- Closed: 23 March 2016
Supply of medicines
- Case type: Markets
- Case state: Closed
- Market sector: Pharmaceuticals
- Opened: 14 May 2015
- Closed: 8 December 2015
Actavis UK / Auden Mckenzie merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 30 March 2015
- Closed: 30 June 2015
Conduct in the pharmaceutical sector investigation
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - administrative priorities
- Opened: 24 June 2014
- Closed: 4 June 2015
Perrigo Company / Omega Pharma Invest merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 13 January 2015
- Closed: 9 April 2015
Coopervision (UK) Holdings / Sauflon Pharmaceuticals merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 19 September 2014
- Closed: 16 January 2015
Review of IMS Health undertakings
- Case type: Reviews of orders and undertakings
- Case state: Closed
- Market sector: Pharmaceuticals
- Opened: 1 January 2012
- Closed: 26 March 2014
ProStrakan Group / Archimedes Pharma merger inquiry
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 6 August 2014
- Closed: 1 December 2014
Omnicell / SurgiChem
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 2 clearance
- Opened: 15 January 2014
- Closed: 8 August 2014
Shire / Viropharma
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Opened: 6 December 2013
- Closed: 8 April 2014
Reviews completed by the CC since the Enterprise Act 2002
- Case type: Reviews of orders and undertakings
- Case state: Closed
- Market sector: Agriculture, environment and natural resources and 8 others
- Opened: 19 June 2013
United Drug plc / Pharmexx UK Ltd
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Closed: 21 December 2012
Christie / Orridge Business Sales Ltd
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 found not to qualify
- Closed: 1 June 2012
Danone / Complan Foods Ltd
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Closed: 8 June 2011
Reckitt Benckiser: alleged abuse of a dominant position
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - infringement Chapter II
- Opened: 1 November 2008
- Closed: 13 April 2011
GlaxoSmithKline plc / Pfizer Inc
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance
- Closed: 9 July 2009
Procter & Gamble Pharmaceuticals UK: alleged abuse of a dominant position
- Case type: CA98 and civil cartels
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: CA98 - no grounds for action
- Opened: 1 October 2005
- Closed: 1 May 2008
Lloyds Pharmacy / Independent Pharmacy Care Centres
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 clearance with undertakings in lieu
- Closed: 23 August 2007
Novartis AG / NeuTec Pharma plc
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 found not to qualify
- Closed: 12 July 2006
AstraZeneca UK Ltd / Cambridge Antibody Technology plc
- Case type: Mergers
- Case state: Closed
- Market sector: Pharmaceuticals
- Outcome type: Mergers - phase 1 found not to qualify
- Closed: 30 May 2006

65 cases

Case type

Case state

Market sector

Outcome

Opened

Closed

65 cases

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK

Cookies on GOV.UK

Competition and Markets Authority cases and projects

Filter

65 cases

Case type

Case state

Market sector

Outcome

Opened

Closed

65 cases

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK